Onward Medical Bv Stock Current Valuation
| 63E Stock | 4.46 0.02 0.45% |
Valuation analysis of ONWARD MEDICAL BV helps investors to measure ONWARD MEDICAL's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that ONWARD MEDICAL's price fluctuation is relatively risky at this time. Calculation of the real value of ONWARD MEDICAL BV is based on 3 months time horizon. Increasing ONWARD MEDICAL's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ONWARD stock is determined by what a typical buyer is willing to pay for full or partial control of ONWARD MEDICAL BV. Since ONWARD MEDICAL is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ONWARD Stock. However, ONWARD MEDICAL's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.46 | Real 3.86 | Hype 4.48 |
The real value of ONWARD Stock, also known as its intrinsic value, is the underlying worth of ONWARD MEDICAL BV Company, which is reflected in its stock price. It is based on ONWARD MEDICAL's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ONWARD MEDICAL's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ONWARD MEDICAL BV helps investors to forecast how ONWARD stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ONWARD MEDICAL more accurately as focusing exclusively on ONWARD MEDICAL's fundamentals will not take into account other important factors: ONWARD MEDICAL BV Company Current Valuation Analysis
ONWARD MEDICAL's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, ONWARD MEDICAL BV has a Current Valuation of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
ONWARD Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ONWARD MEDICAL's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ONWARD MEDICAL could also be used in its relative valuation, which is a method of valuing ONWARD MEDICAL by comparing valuation metrics of similar companies.ONWARD MEDICAL is currently under evaluation in current valuation category among its peers.
ONWARD Fundamentals
| Return On Equity | -2.89 | |||
| Return On Asset | -0.34 | |||
| Operating Margin | (19.04) % | |||
| Shares Owned By Insiders | 41.37 % | |||
| Shares Owned By Institutions | 39.43 % | |||
| Revenue | 1.78 M | |||
| Gross Profit | (10.58 M) | |||
| EBITDA | (33.44 M) | |||
| Book Value Per Share | 2.28 X | |||
| Earnings Per Share | (3.62) X | |||
| Number Of Employees | 76 | |||
| Market Capitalization | 34.4 M |
About ONWARD MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ONWARD MEDICAL BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ONWARD MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ONWARD MEDICAL BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ONWARD Stock
ONWARD MEDICAL financial ratios help investors to determine whether ONWARD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ONWARD with respect to the benefits of owning ONWARD MEDICAL security.